Tyler CVC - Cardiovascular Consultants
Tyler CVC - Cardiovascular Consultants: About Us
Tyler CVC - Cardiovascular Consultants: Our Team
Tyler CVC - Cardiovascular Consultants: Conditions & Treatment
Tyler CVC - Cardiovascular Consultants: Patient Information
Tyler CVC - Cardiovascular Consultants: Locations and Affiliations
Tyler CVC - Cardiovascular Consultants: Contact Us
Tyler CVC - Cardiovascular Consultants: Employment Opportunities
Tyler CVC - Cardiovascular Consultants
Tyler CVC - Cardiovascular Consultants
Tyler CVC - Cardiovascular Consultants: What's New at Tyler
Tyler CVC - Cardiovascular Consultants
Call 800 543-2783 to schedule your appointment TODAY!
619 S. Fleishel · Tyler, Texas 75701 · Phone: 903-595-5514 · Toll-Free: 800-543-2783
Tyler CVC - Cardiovascular Consultants: Our Team

Brent O. Davis, M.D., F.A.C.C. - Professional Research

Principal Investigator

  • IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) A Multicenter, double-blind, randomized study to establish the clinical benefit and safety of Vytorin (ezetimibe/simvastatin tablet) vs. simvastatin monotherapy in high-risk subjects presenting with acute coronary syndrome (ACS)
Sub-Investigator
  • ENDEAVOR IV - A randomized, controlled trial of the Medtronic Endeavor drug (ABT-578) eluting coronary stent system versus the Taxus paclitaxel-eluting coronary stent system in De Novo native coronary artery lesions
  • TENACITY – A randomized, Multicenter, double-blind, Abciximab-controlled study to evaluate the efficacy of Tirofiban versus Abciximab among subjects undergoing percutaneous coronary intervention with stent placement receiving Bivalirudin or Heparin. Protocol #0120-0401
  • EARLY ACS – Early Glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome: A randomized, placebo-controlled trial evaluating the clinical benefits of early front-loaded Eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome
  • TIMI 38 – A comparison of (CS-747) and Clopidogrel in acute coronary syndrome subjects who are to undergo percutaneous coronary intervention
 
 
About Us | Our Team | Conditions & Treatments | Patient Information | Locations | Contact Us | Home
 

Copyright ©2008 Tyler Cardiovascular Consultants, PA
619 S. Fleishel • Tyler, Texas 75701 • 903-595-5514 • Toll-Free: 800-543-2783 • info@tylercvc.com

 

Medical Websites by HealthPresence